Table 3.
Group and Blood Vessel | Basal Period | Experimental Period
|
|||
---|---|---|---|---|---|
P1 | P2 | P3 | P4 | ||
Hepatic artery | |||||
SAL | 6.1±0.6 | 7.7±0.6 | 8.6±0.8 | 9.2±1.1 | 9.7±1.4 |
HTP | 5.7±0.9 | 6.0±1.2 | 7.3±2.1 | 7.8±2.0 | 7.9±1.9 |
Portal vein | |||||
SAL | 24.2±2.1 | 20.3±2.1 | 21.0±2.1 | 20.6±2.2 | 20.4±2.1 |
HTP | 26.6±2.4 | 21.2±1.2 | 22.9±1.6 | 21.9±1.5 | 21.2±1.3 |
Values are means ± SE. (Units are ml·kg−1·min−1). SAL dogs (n = 7) received intraportal saline infusion during P1–P4; HTP dogs (n = 6) received saline during P1 and intraportal 5-HTP at 10, 20, and 40 μg·kg−1·min−1, respectively, during P2–P4. There were no significant differences between groups.